China Health Technology Group Holding Company Limited
CHBOD
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 64.19% | 65.50% | -22.51% | -23.68% | -18.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 64.19% | 65.50% | -22.51% | -23.68% | -18.69% |
| Cost of Revenue | 86.35% | 87.83% | 0.70% | -0.81% | -16.33% |
| Gross Profit | -25.83% | -25.21% | -127.96% | -127.53% | -27.05% |
| SG&A Expenses | 5.96% | 6.80% | -4.15% | -5.60% | 49.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.45% | 57.70% | -0.87% | -2.36% | 0.14% |
| Operating Income | -28.58% | -29.64% | -101.52% | -98.48% | -503.30% |
| Income Before Tax | -97.49% | -97.47% | 83.30% | 83.55% | 16,041.03% |
| Income Tax Expenses | 4,300.00% | 4,400.00% | -99.71% | -99.71% | -- |
| Earnings from Continuing Operations | -97.52% | -97.50% | 85.75% | 85.95% | 16,040.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -97.52% | -97.50% | 85.75% | 85.95% | 16,040.91% |
| EBIT | -28.58% | -29.64% | -101.52% | -98.48% | -503.30% |
| EBITDA | -28.00% | -29.03% | -99.20% | -96.19% | -499.83% |
| EPS Basic | -98.02% | -98.02% | 97.74% | 97.79% | 2,913.92% |
| Normalized Basic EPS | -12.82% | -15.38% | 92.76% | 92.88% | 90.05% |
| EPS Diluted | -98.02% | -98.02% | 97.74% | 97.79% | 2,913.92% |
| Normalized Diluted EPS | -12.82% | -15.38% | 92.76% | 92.88% | 90.05% |
| Average Basic Shares Outstanding | 26.32% | 26.32% | 549.04% | 549.04% | 469.04% |
| Average Diluted Shares Outstanding | 26.32% | 26.32% | 549.04% | 549.04% | 469.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |